Indian Generic Drugs Could Shake Up Global Weight Loss Market

In India, the patent for semaglutide – the active ingredient in Novo Nordisk's Wegovy and Ozempic – is expiring. Will this change the global landscape of obesity treatment?

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

deloSerbian152d ago

Indijska generična zdravila bi lahko premešala globalni trg hujšanja

V Indiji poteče patent za semaglutid – učinkovino v zdravilih Wegovy in Ozempic podjetja Novo Nordisk. Bo to spremenilo globalno sliko zdravljenja debelosti?

Read full article →

PERSPECTA

PERSPECTA

Indian Generic Drugs Could Shake Up Global Weight Loss Market

Sources

Indijska generična zdravila bi lahko premešala globalni trg hujšanja

Related Stories

Hayden Panettiere Dies at 36; Cardiac Arrest Cited, No Trauma Found

West Nile Fever Cases and Fatalities Reported in Serbia and North Macedonia

Metro Manila Inundated by Heavy Monsoon Rains

Hayden Panettiere's Life and Career Remembered Amidst Personal Struggles

PERSPECTA